LINC-ROR and early-onset autosomal dominant Alzheimer disease: Considering the proposed roles of NRs like the RXR and ROR in CNS regeneration and neuroinflammation, a favorable safety profile would increase the attractiveness of those NRs as therapeutic targets for diseases like multiple sclerosis and Alzheimer’s disease [71].